Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Operating Return On Assets

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in Percent.

The item "Operating-Return-On-Assets" stands at 10.34 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Operating Return On Assets" stands at 10.34 Percent. This represents an increase of 3.70 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 40.69 compared to the value the year prior.
The Serie's long term average value is -9.11 percent. It's latest available value, on 09/30/2025, is 19.45 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +43.62 .
The Serie's change in percentage points from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0.

Operating Return On Assets for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Operating Return On Assets905,699,262,464.00
LogoJohnson & Johnson - Operating Return On Assets486,508,953,600.00
LogoAbbVie Inc - Operating Return On Assets399,570,305,024.00
LogoRoche Holding AG - Operating Return On Assets317,433,206,677.55
LogoAstraZeneca PLC - Operating Return On Assets280,205,508,085.11